Men hold secret to protect women from multiple sclerosis
Men are much less likely to get multiple sclerosis (MS) than women and one reason is that they are protected by high levels of testosterone.
Jan 29, 2018
0
1069
Men are much less likely to get multiple sclerosis (MS) than women and one reason is that they are protected by high levels of testosterone.
Jan 29, 2018
0
1069
The immune system is supposed to protect from external microbial invaders, but sometimes it turns its efforts inward, potentially resulting in autoimmune diseases. In a new study, researchers from Osaka University have discovered ...
Jul 2, 2020
0
563
A compound derived from immune cells treats psoriasis in mice and holds promise for other autoimmune diseases, according to a new study from Washington University School of Medicine in St. Louis.
Apr 18, 2018
0
888
Endogenous proteins that play a vital part in allergies and parasitic infection can prevent the immune system from wrongly attacking the body and causing inflamed joints, a study from Karolinska Institutet in Sweden published ...
Jan 21, 2020
0
2784
Researchers in Dr. Leona Gilbert's research group at the University of Jyväskylä have proposed a novel mechanism for how a common viral infection could lead to an autoimmune disease. Dr. Gilbert's team demonstrated for ...
Jun 4, 2019
0
174
A team of scientists led by Professor Karsten Hiller from the Braunschweig Center for Systems Biology BRICS has discovered an endogenous, anti-inflammatory substance: mesaconic acid. This molecule could be a drug candidate ...
Jun 23, 2022
0
763
(HealthDay)—A preventive monoclonal antibody injection for people at high risk for developing severe COVID-19 after exposure to the coronavirus has been approved by the U.S. Food and Drug Administration.
Aug 4, 2021
1
110
A new type of vaccine developed by researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) has shown in the lab setting that it can completely reverse autoimmune diseases like multiple sclerosis, ...
Sep 11, 2023
0
710
A team of researchers at Atara Biotherapeutics has conducted a small Phase I clinical trial of a therapeutic called ATA188 that targets Epstein-Barr infections (EBV) as a treatment for multiple sclerosis (MS). Representatives ...
Evidence has long suggested multiple sclerosis (MS) is an autoimmune disease, but researchers have been puzzled because they found the same T cells that attack the myelin sheathing around nerve cells in MS patients are present ...
May 14, 2015
0
499